Natrecor has been demonstrated to decrease shortness of breath.
Collectively, changes in these ionic concentrations have been demonstrated to decrease resting membrane potential and impair sarcolemmal excitability [13].
Hypercapnia has been demonstrated to decrease cerebrovascular resistance and increase blood flow, suggesting a potential benefit in patients suffering from ischemic brain injury [8, 45].
This model has been indirectly demonstrated for ICU admissions from Emergency Department [11] where an earlier transfer to ICU has been demonstrated to decrease both ICU and hospital mortality.
A CVP > 8 mmHg has been demonstrated to decrease microcirculatory flow, as well as renal blood flow and is associated with an increased risk of renal failure and death.
One intervention that has been demonstrated to decrease maternal mortality is use of family planning and modern contraception, yet rates of use in sub-Saharan countries with the highest rates of maternal death remain very low.
Although the use of oxytocin for labor induction has been demonstrated to decrease the time to delivery compared with expectant management, no studies have evaluated the effectiveness of cervical ripening with a Foley bulb to additionally decrease the time to delivery.
The K65R mutation has been demonstrated to decrease pyrophosphorolysis [6] and ATP-dependent primer rescue [36], and re-sensitizes viruses carrying the TAM mutations to AZT [37], [38].
THL has been demonstrated to decrease mycolic acid synthesis, leading to defects in the mycobacterial cell wall, though the targets of its antimycobacterial action were unknown.
The specific neuronal NOS (nNOS) inhibitor, 7-nitro-indazole, has been demonstrated to decrease REMS exclusively [33], to reduce both REMS and NREMS as well as EEG amplitude [34], or to have most of all an effect on NREMS [35], respectively.
Inflammation of the bovine uterus has been demonstrated to decrease reproductive performance.
